Leishmania donovani p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis

The acquisition of immunity following subclinical or resolved infection with the intracellular parasite Leishmania donovani suggests that vaccination could prevent visceral leishmaniasis (VL). The LACK (Leishmania homolog of receptors for activated C kinase) antigen is of interest as a vaccine candi...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Melby, Peter C., Yang, Jue, Zhao, Weiguo, Perez, Luis E., Cheng, Jun
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2001
Предметы:
Microbial Immunity and Vaccines
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC98557/
https://ncbi.nlm.nih.gov/pubmed/11447143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.8.4719-4725.2001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы